| 1 |
Hume DM,Merrill JP,Miller BF, et al. Experiences with renal homotransplantation in the human: report of nine cases[J]. J Clin Invest, 1955, 34(2): 327-382.
|
| 2 |
Alexandre GP,Squifflet JP,De Bruyere M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts[J]. Transplant Proc, 1987, 19(6): 4538-4542.
|
| 3 |
Sonnenday CJ,Warren DS,Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy[J]. Am J Transplant, 2004, 4(8): 1315-1322.
|
| 4 |
Tyden G,Kumlien G,Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab[J]. Transplantation, 2003, 76(4): 730-731.
|
| 5 |
Tanabe K,Ishida H,Inui M, et al. ABO-incompatible kidney transplantation: long-term outcomes[J]. Clin Transpl, 2013: 307-312.
|
| 6 |
Takahashi K,Saito K. ABO-incompatible kidney transplantation[J]. Transplant Rev(Orlando), 2013, 27(1): 1-8.
|
| 7 |
Aikawa A,Saito K,Takahashi K. Trends in ABO-incompatible kidney transplantation[J]. Exp Clin Transplant, 2015, 13(Suppl 1): 18-22.
|
| 8 |
Opelz G,Morath C,Susal C, et al. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers[J]. Transplantation, 2015, 99(2): 400-404.
|
| 9 |
Montgomery JR,Berger JC,Warren DS, et al. Outcomes of ABO-incompatible kidney transplantation in the United States[J]. Transplantation, 2012, 93(6): 603-609.
|
| 10 |
王毅,罗志刚,桂培根, 等. 供、受者ABO血型不相容保留受者脾脏的亲属活体供肾移植一例[J]. 中华器官移植杂志, 2007, 28(11): 694-695.
|
| 11 |
Segev DL,Simpkins CE,Warren DS, et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment[J]. Am J Transplant, 2005, 5(10): 2570-2575.
|
| 12 |
Tanabe K. Japanese experience of ABO-incompatible living kidney transplantation[J]. Transplantation, 2007, 84(12 Suppl): S4-S7.
|
| 13 |
Genberg H,Kumlien G,Wennberg L, et al. Isoagglutinin adsorption in ABO-incompatible transplantation[J]. Transfus Apher Sci, 2010, 43(2): 231-235.
|
| 14 |
Lo P,Sharma A,Craig JC, et al. Preconditioning therapy in ABO-incompatible living kidney transplantation: A systematic review and meta-analysis[J]. Transplantation, 2016, 100(4): 933-942.
|
| 15 |
Galili U. Xenotransplantation and ABO incompatible transplantation: the similarities they share[J]. Transfus Apher Sci, 2006, 35(1): 45-58.
|
| 16 |
Tyden G,Donauer J,Wadstrom J, et al. Implementation of a protocol for ABO-incompatible kidney transplantation-a three-center experience with 60 consecutive transplantations[J]. Transplantation, 2007, 83(9): 1153-1155.
|
| 17 |
Fuchinoue S,Ishii Y,Sawada T, et al. The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction[J]. Transplantation, 201, 91(8): 853-857.
|
| 18 |
中华医学会. 临床诊疗指南：器官移植学分册(2010版)[M]. 北京: 人民卫生出版社, 2010.
|
| 19 |
Shimmura H,Tanabe K,Ishikawa N, et al. Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation[J]. Transplantation, 2000, 70(9): 1331-1335.
|
| 20 |
Gloor JM,Lager DJ,Moore SB, et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors[J]. Transplantation, 2003, 75(7): 971-977.
|
| 21 |
Chung BH,Lim JU,Kim Y, et al. Impact of the baseline anti-A/B antibody titer on the clinical outcome in ABO-incompatible kidney transplantation[J]. Nephron Clin Pract, 2013, 124(1-2): 79-88.
|
| 22 |
Shimmura H,Tanabe K,Ishida H, et al. Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression[J]. Transplantation, 2005, 80(7): 985-988.
|
| 23 |
van Agteren M,Weimar W,de Weerd AE, et al. The first fifty ABO blood group incompatible kidney transplantations: the rotterdam experience[J]. J Transplant, 2014: 913902.
|
| 24 |
Won D,Choe W,Kim HJ, et al. Significance of isoagglutinin titer in ABO-incompatible kidney transplantation[J]. J Clin Apher, 2014, 29(5): 243-250.
|
| 25 |
Mital D,Hammes E. Indications for renal transplantation// Saclarides JT,Myers AJ,Millikan WK. Common surgical diseases: An algorithmic approach to problem solving[M]. New York: Springer New York, 2014: 239-242.
|
| 26 |
Gohh RY,Yango AF,Morrissey PE, et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients[J]. Am J Transplant, 2005, 5(12): 2907-2912.
|
| 27 |
Andrews P,Burnapp L,Manas D, et al. Summary of the British Transplantation Society/Renal Association U. K. guidelines for living donor kidney transplantation[J]. Transplantation, 2012, 93(7): 666-673.
|
| 28 |
Opelz G. Strength of HLA-A, HLA-B, and HLA-DR mismatches in relation to short- and long-term kidney graft survival. Collaborative Transplant Study[J]. Transpl Int, 1992, 5(Suppl 1): S621-S624.
|
| 29 |
Lefaucheur C,Loupy A,Hill GS, et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation[J]. J Am Soc Nephrol, 2010, 21(8): 1398-1406.
|
| 30 |
Thammanichanond D,Ingsathit A,Mongkolsuk T, et al. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation[J]. Asian Pac J Allergy Immunol, 2012, 30(1): 48-54.
|
| 31 |
Hirai T,Kohei N,Omoto K, et al. Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection[J]. Transpl Int, 2012, 25(9): 925-934.
|
| 32 |
Toki D,Ishida H,Horita S, et al. Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation[J]. Transplantation, 2009, 88(10): 1186-1193.
|
| 33 |
Barnett AN,Hadjianastassiou VG,Mamode N. Rituximab in renal transplantation[J]. Transpl Int, 2013, 26(6): 563-575.
|
| 34 |
Gloor J,Stegall M. ABO-incompatible kidney transplantation with and without splenectomy[J]. Transplantation, 2006, 82(5): 720.
|
| 35 |
Genberg H,Kumlien G,Wennberg L, et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up[J]. Transplantation, 2008, 85(12): 1745-1754.
|
| 36 |
Kohei N,Hirai T,Omoto K, et al. Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period[J]. Am J Transplant, 2012, 12(2): 469-476.
|
| 37 |
Montgomery RA,Locke JE,King KE, et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation[J]. Transplantation, 2009, 87(8): 1246-1255.
|
| 38 |
Tobian AA,Shirey RS,Montgomery RA, et al. ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation[J]. Am J Transplant, 2010, 10(5): 1247-1253.
|
| 39 |
Tyden G,Kumlien G,Genberg H, et al. The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy[J]. Xenotransplantation, 2006, 13(2): 105-107.
|
| 40 |
Wilpert J,Fischer KG,Pisarski P, et al. Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis[J]. Nephrol Dial Transplant, 2010, 25(11): 3778-3786.
|
| 41 |
Muramatsu M,Gonzalez HD,Cacciola R, et al. ABO incompatible renal transplants: Good or bad? [J]. World J Transplant, 2014, 4(1): 18-29.
|
| 42 |
Galliford J,Charif R,Chan KK, et al. ABO incompatible living renal transplantation with a steroid sparing protocol[J]. Transplantation, 2008, 86(7): 901-906.
|
| 43 |
Focosi D. Acquired factor Ⅷ deficiency after desensitization as a potential contributor to postoperative bleeding: more than meets the eye[J]. Transpl Int, 2015, 28(2): 246-247.
|
| 44 |
Humar A,Matas AJ. Surgical complications after kidney transplantation[J]. Semin Dial, 2005, 18(6): 505-510.
|
| 45 |
Kim MH,Jun KW,Hwang JK, et al. Risk factors for postoperative bleeding in ABO-incompatible kidney transplantation[J]. Clin Transplant, 2015, 29(4): 365-372.
|
| 46 |
de Weerd AE,van Agteren M,Leebeek FW, et al. ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption[J]. Transpl Int, 2015, 28(1): 25-33.
|
| 47 |
Takahashi K,Saito K,Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan[J]. Am J Transplant, 2004, 4(7): 1089-1096.
|
| 48 |
Haas M,Rahman MH,Racusen LC, et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings[J]. Am J Transplant, 2006, 6(8): 1829-1840.
|
| 49 |
Habicht A,Broker V,Blume C, et al. Increase of infectious complications in ABO-incompatible kidney transplant recipients-a single centre experience[J]. Nephrol Dial Transplant, 2011, 26(12): 4124-4131.
|
| 50 |
Lentine KL,Axelrod D,Klein C, et al. Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of medicare-insured recipients[J]. Transplantation, 2014, 98(1): 54-65.
|
| 51 |
Kelesidis T,Daikos G,Boumpas D, et al. Does rituximab increase the incidence of infectious complications? A narrative review[J]. Int J Infect Dis, 2011, 15(1): e2-e16.
|
| 52 |
Kaplan A. Complications of apheresis[J]. Semin Dial, 2012, 25(2): 152-158.
|
| 53 |
Moriya Y,Yamaji K,Kanai Y, et al. The effectiveness of intravenous human immunoglobulin treatment after plasmapheresis in restoring serum immunoglobulin levels: a preliminary study[J]. Ther Apher, 2002, 6(2): 154-158.
|
| 54 |
Biglarnia AR,Nilsson B,Nilsson Ekdahl K, et al. Desensitization with antigen-specific immunoadsorption interferes with complement in ABO-incompatible kidney transplantation[J]. Transplantation, 2012, 93(1): 87-92.
|
| 55 |
Hall EC,Engels EA,Montgomery RA, et al. Cancer risk after ABO-incompatible living-donor kidney transplantation[J]. Transplantation, 2013, 96(5): 476-479.
|
| 56 |
Masterson R,Hughes P,Walker RG, et al. ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone[J]. Am J Transplant, 2014, 14(12): 2807-2813.
|
| 57 |
Stewart ZA,Locke JE,Montgomery RA, et al. ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis[J]. Liver Transpl, 2009, 15(8): 883-893.
|
| 58 |
Koestner SC,Kappeler A,Schaffner T, et al. Histo-blood group type change of the graft from B to O after ABO mismatched heart transplantation[J]. Lancet, 2004, 363(9420): 1523-1525.
|
| 59 |
Montgomery RA,Lonze BE,King KE, et al. Desensitization in HLA-incompatible kidney recipients and survival[J]. N Engl J Med, 2011, 365(4): 318-326.
|